• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨噬细胞中的信号通路:分子机制与治疗靶点。

Signaling pathways in macrophages: molecular mechanisms and therapeutic targets.

作者信息

Li Ming, Wang Mengjie, Wen Yuanjia, Zhang Hongfei, Zhao Guang-Nian, Gao Qinglei

机构信息

Department of Gynecological Oncology Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.

National Clinical Research Center for Obstetrics and Gynecology Cancer Biology Research Center (Key Laboratory of the Ministry of Education) Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China.

出版信息

MedComm (2020). 2023 Sep 11;4(5):e349. doi: 10.1002/mco2.349. eCollection 2023 Oct.

DOI:10.1002/mco2.349
PMID:37706196
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10495745/
Abstract

Macrophages play diverse roles in development, homeostasis, and immunity. Accordingly, the dysfunction of macrophages is involved in the occurrence and progression of various diseases, such as coronavirus disease 2019 and atherosclerosis. The protective or pathogenic effect that macrophages exert in different conditions largely depends on their functional plasticity, which is regulated via signal transduction such as Janus kinase-signal transducer and activator of transcription, Wnt and Notch pathways, stimulated by environmental cues. Over the past few decades, the molecular mechanisms of signaling pathways in macrophages have been gradually elucidated, providing more alternative therapeutic targets for diseases treatment. Here, we provide an overview of the basic physiology of macrophages and expound the regulatory pathways within them. We also address the crucial role macrophages play in the pathogenesis of diseases, including autoimmune, neurodegenerative, metabolic, infectious diseases, and cancer, with a focus on advances in macrophage-targeted strategies exploring modulation of components and regulators of signaling pathways. Last, we discuss the challenges and possible solutions of macrophage-targeted therapy in clinical applications. We hope that this comprehensive review will provide directions for further research on therapeutic strategies targeting macrophage signaling pathways, which are promising to improve the efficacy of disease treatment.

摘要

巨噬细胞在发育、体内平衡和免疫过程中发挥着多种作用。因此,巨噬细胞功能障碍与多种疾病的发生和发展有关,如2019冠状病毒病和动脉粥样硬化。巨噬细胞在不同条件下发挥的保护或致病作用在很大程度上取决于其功能可塑性,这种可塑性通过信号转导来调节,如Janus激酶-信号转导子和转录激活子、Wnt和Notch信号通路,并受环境线索刺激。在过去几十年中,巨噬细胞信号通路的分子机制已逐渐阐明,为疾病治疗提供了更多的替代治疗靶点。在此,我们概述巨噬细胞的基本生理学,并阐述其内部的调节途径。我们还阐述了巨噬细胞在包括自身免疫性、神经退行性、代谢性、感染性疾病和癌症等疾病发病机制中所起的关键作用,重点关注探索信号通路成分和调节因子调控的巨噬细胞靶向策略的进展。最后,我们讨论巨噬细胞靶向治疗在临床应用中的挑战及可能的解决方案。我们希望这一全面综述将为进一步研究靶向巨噬细胞信号通路的治疗策略提供方向,有望提高疾病治疗的疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87bc/10495745/ff8585d2bad5/MCO2-4-e349-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87bc/10495745/c4ac774d0992/MCO2-4-e349-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87bc/10495745/eade1b30d0ca/MCO2-4-e349-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87bc/10495745/d9ab661d6fd3/MCO2-4-e349-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87bc/10495745/1137513bb2ca/MCO2-4-e349-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87bc/10495745/9f86bfd717db/MCO2-4-e349-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87bc/10495745/ff8585d2bad5/MCO2-4-e349-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87bc/10495745/c4ac774d0992/MCO2-4-e349-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87bc/10495745/eade1b30d0ca/MCO2-4-e349-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87bc/10495745/d9ab661d6fd3/MCO2-4-e349-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87bc/10495745/1137513bb2ca/MCO2-4-e349-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87bc/10495745/9f86bfd717db/MCO2-4-e349-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87bc/10495745/ff8585d2bad5/MCO2-4-e349-g007.jpg

相似文献

1
Signaling pathways in macrophages: molecular mechanisms and therapeutic targets.巨噬细胞中的信号通路:分子机制与治疗靶点。
MedComm (2020). 2023 Sep 11;4(5):e349. doi: 10.1002/mco2.349. eCollection 2023 Oct.
2
Macrophage plasticity: signaling pathways, tissue repair, and regeneration.巨噬细胞可塑性:信号通路、组织修复与再生
MedComm (2020). 2024 Aug 1;5(8):e658. doi: 10.1002/mco2.658. eCollection 2024 Aug.
3
Macrophage polarization and function with emphasis on the evolving roles of coordinated regulation of cellular signaling pathways.巨噬细胞极化和功能,重点是细胞信号通路协调调控的作用不断演变。
Cell Signal. 2014 Feb;26(2):192-7. doi: 10.1016/j.cellsig.2013.11.004. Epub 2013 Nov 9.
4
Mitochondrial biogenesis: pharmacological approaches.线粒体生物合成:药理学方法。
Curr Pharm Des. 2014;20(35):5507-9. doi: 10.2174/138161282035140911142118.
5
The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids.JAK/STAT 和 IRS/PI3K 信号通路在神经退行性疾病中的关键作用:多酚和生物碱的作用机制。
Phytomedicine. 2023 Apr;112:154686. doi: 10.1016/j.phymed.2023.154686. Epub 2023 Jan 31.
6
Macrophages: The Good, the Bad, and the Gluttony.巨噬细胞:亦善亦恶亦饕餮。
Front Immunol. 2021 Aug 12;12:708186. doi: 10.3389/fimmu.2021.708186. eCollection 2021.
7
Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives.癌症相关成纤维细胞中的信号通路:最新进展和未来展望。
Cancer Commun (Lond). 2023 Jan;43(1):3-41. doi: 10.1002/cac2.12392. Epub 2022 Nov 24.
8
Macrophage signaling pathways: a novel target in renal disease.巨噬细胞信号通路:肾脏疾病的新靶点。
Semin Nephrol. 2010 May;30(3):334-44. doi: 10.1016/j.semnephrol.2010.03.008.
9
Protein Thiol Redox Signaling in Monocytes and Macrophages.单核细胞和巨噬细胞中的蛋白质硫醇氧化还原信号传导
Antioxid Redox Signal. 2016 Nov 20;25(15):816-835. doi: 10.1089/ars.2016.6697. Epub 2016 Jul 13.
10
Uremic Toxin Indoxyl Sulfate Promotes Proinflammatory Macrophage Activation Via the Interplay of OATP2B1 and Dll4-Notch Signaling.尿毒症毒素吲哚硫酸酯通过 OATP2B1 和 Dll4-Notch 信号的相互作用促进促炎型巨噬细胞的激活。
Circulation. 2019 Jan 2;139(1):78-96. doi: 10.1161/CIRCULATIONAHA.118.034588.

引用本文的文献

1
8-Methoxybicolosin C from Attenuates Inflammation and Oxidative Stress via Nrf2/HO-1 and NF-κB/MAPK Pathways in Lipopolysaccharide-Induced Mouse Kupffer Cells.来自[具体来源未提及]的8-甲氧基比考洛辛C通过Nrf2/HO-1和NF-κB/MAPK途径减轻脂多糖诱导的小鼠库普弗细胞中的炎症和氧化应激。
J Microbiol Biotechnol. 2025 Aug 18;35:e2503013. doi: 10.4014/jmb.2503.03013.
2
Hyperuricemia in ob/ob mice relates to hepatocellular pyruvate metabolism/ xanthine oxidase axis.ob/ob小鼠的高尿酸血症与肝细胞丙酮酸代谢/黄嘌呤氧化酶轴有关。
PLoS One. 2025 Aug 6;20(8):e0328794. doi: 10.1371/journal.pone.0328794. eCollection 2025.
3
Dynamic macrophage phenotypes in autoimmune and inflammatory rheumatic diseases.

本文引用的文献

1
Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial.吸入性泛 Janus 激酶抑制剂奈泽利替尼治疗住院 COVID-19 患者的疗效和安全性:一项 2 期临床试验结果。
BMJ Open Respir Res. 2023 Jul;10(1). doi: 10.1136/bmjresp-2023-001627.
2
Physiology and diseases of tissue-resident macrophages.组织驻留巨噬细胞的生理学和疾病。
Nature. 2023 Jun;618(7966):698-707. doi: 10.1038/s41586-023-06002-x. Epub 2023 Jun 21.
3
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
自身免疫性和炎性风湿性疾病中的动态巨噬细胞表型
Nat Rev Rheumatol. 2025 Jul 28. doi: 10.1038/s41584-025-01279-w.
4
The M2 Macrophages Importance Role in Psoriasis.M2巨噬细胞在银屑病中的重要作用
Immun Inflamm Dis. 2025 Jun;13(6):e70211. doi: 10.1002/iid3.70211.
5
Immunopharmacology of gastric cancer-deciphering immune cell subset responses and nanoparticle-mediated targeting.胃癌的免疫药理学——解析免疫细胞亚群反应与纳米颗粒介导的靶向作用
Front Pharmacol. 2025 May 19;16:1611234. doi: 10.3389/fphar.2025.1611234. eCollection 2025.
6
IL-37 Mitigates the Inflammatory Response in Macrophages Induced by SARS-CoV-2 Omicron Infection Through the NF-κB Signaling Pathway.白细胞介素-37通过NF-κB信号通路减轻SARS-CoV-2奥密克戎感染诱导的巨噬细胞炎症反应。
MedComm (2020). 2025 May 31;6(6):e70229. doi: 10.1002/mco2.70229. eCollection 2025 Jun.
7
Enzyme-Based Anti-Inflammatory Therapeutics for Inflammatory Diseases.用于炎症性疾病的基于酶的抗炎疗法
Pharmaceutics. 2025 May 2;17(5):606. doi: 10.3390/pharmaceutics17050606.
8
Targeting mTOR in myeloid cells prevents infection-associated inflammation.靶向髓系细胞中的mTOR可预防感染相关炎症。
iScience. 2025 Mar 4;28(4):112163. doi: 10.1016/j.isci.2025.112163. eCollection 2025 Apr 18.
9
Exosome-like vesicles encapsulated with specific microRNAs accelerate burn wound healing and ameliorate scarring.包裹特定微小RNA的外泌体样囊泡可加速烧伤创面愈合并减轻瘢痕形成。
J Nanobiotechnology. 2025 Apr 2;23(1):264. doi: 10.1186/s12951-025-03337-7.
10
Targeting stemness pathways modulates macrophage polarization and reprograms the tumor microenvironment.靶向干性通路可调节巨噬细胞极化并重塑肿瘤微环境。
Front Immunol. 2025 Mar 14;16:1513404. doi: 10.3389/fimmu.2025.1513404. eCollection 2025.
COVID-19 住院患者中接受皮质类固醇治疗:一项随机、对照、开放标签、平台试验
Lancet. 2023 May 6;401(10387):1499-1507. doi: 10.1016/S0140-6736(23)00510-X. Epub 2023 Apr 13.
4
Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial.阿那白滞素联合标准治疗用于重症 COVID-19 患者的疗效和安全性:一项随机 2/3 期临床试验。
JAMA Netw Open. 2023 Apr 3;6(4):e237243. doi: 10.1001/jamanetworkopen.2023.7243.
5
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial.古塞库单抗联合戈利木单抗与古塞库单抗或戈利木单抗单药治疗溃疡性结肠炎患者的疗效比较(VEGA):一项随机、双盲、对照、2期概念验证试验
Lancet Gastroenterol Hepatol. 2023 Apr;8(4):307-320. doi: 10.1016/S2468-1253(22)00427-7. Epub 2023 Feb 1.
6
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.巴瑞替尼治疗住院成人严重或危重症 COVID-19 的疗效和安全性(Bari-SolidAct):一项随机、双盲、安慰剂对照的 3 期临床试验。
Crit Care. 2023 Jan 10;27(1):9. doi: 10.1186/s13054-022-04205-8.
7
The effect of Fingolimod on patients with moderate to severe COVID-19.芬戈莫德对中重度 COVID-19 患者的影响。
Pharmacol Res Perspect. 2023 Feb;11(1):e01039. doi: 10.1002/prp2.1039.
8
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial.阿奇霉素对比安慰剂治疗低降钙素原相关下呼吸道感染的疗效和安全性:一项随机、安慰剂对照、双盲、非劣效性试验。
Lancet Infect Dis. 2023 Apr;23(4):484-495. doi: 10.1016/S1473-3099(22)00735-6. Epub 2022 Dec 13.
9
Efficacy and Safety of Pacritinib vs Placebo for Patients With Severe COVID-19: A Phase 2 Randomized Clinical Trial.帕克里替尼治疗重症 COVID-19 患者的疗效和安全性:一项 2 期随机临床试验。
JAMA Netw Open. 2022 Dec 1;5(12):e2242918. doi: 10.1001/jamanetworkopen.2022.42918.
10
Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases.针对 CSF-1R 代表了一种调节炎症性疾病的有效策略。
Pharmacol Res. 2023 Jan;187:106566. doi: 10.1016/j.phrs.2022.106566. Epub 2022 Nov 21.